Jul 29, 2019 / 05:30AM GMT
Operator
Good morning, ladies and gentlemen. Welcome to the Eris Lifesciences Q1 FY '20 Results Conference Call Hosted by Axis Capital Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Prakash Agarwal from Axis Capital Limited. Thank you. And over to you, sir.
Prakash Agarwal - Axis Capital Limited, Research Division - Executive Director of Pharmaceuticals
Yes. Thank you all. Welcome on behalf of Axis Capital to the Q1 Fiscal '20 Eris Lifesciences conference call represented by senior management team. Over to you, sir.
Amit Indubhushan Bakshi - Eris Lifesciences Limited - Chairman & MD
Good morning. Thanks for this opportunity. What I'll do is I'll just call off with the presentation which we have put just to get the perspective right and then take up questions as usual.
So the first quarter FY '20, the company has shown a growth of around 12.8% versus 7.9% for the IPM. This is for as per the AICD data, which adds to the growth momentum of
Q1 2020 Eris Lifesciences Ltd Earnings Call Transcript
Jul 29, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers